Prospective, Multicenter, Single-Arm Study of Vanquish™ Water Vapor Ablation for Prostate Cancer

The purpose of this study is to evaluate the safety and efficacy of the Vanquish Water Vapor Ablation Device ("Vanquish") in treating subjects with Gleason Grade Group 2 (GGG2) localized intermediate-risk prostate cancer.

For more information please visit https://clinicaltrials.gov/study/NCT05683691

Interested in Volunteering for the Study?

If you would like more information about this study, please call us at 318-212-8130 .